Successful treatment of chronic hepatitis C in a hemodialysis | Zendy

Ivana Milošević | Zendy; Uroš Karić | Zendy; Ivana Pešić-Pavlović | Zendy; Goran Stevanović | Zendy; Aleksandra Barać | Zendy; Marijana Smiljanić | Zendy; Aleksandra Arsenović | Zendy; Olja Stevanović | Zendy; Miljana Đonin-Nenezić | Zendy; Branko Brmbolić | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Successful treatment of chronic hepatitis C in a hemodialysis

Author(s) -

Ivana Milošević,

Uroš Karić,

Ivana Pešić-Pavlović,

Goran Stevanović,

Aleksandra Barać,

Marijana Smiljanić,

Aleksandra Arsenović,

Olja Stevanović,

Miljana Đonin-Nenezić,

Branko Brmbolić

Publication year - 2018

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.10257

Subject(s) - dasabuvir , ombitasvir , ribavirin , medicine , hemodialysis , paritaprevir , chronic hepatitis , ritonavir , hepatitis c , intensive care medicine , virology , viral load , virus , antiretroviral therapy

We present the first case of successful direct acting antiviral therapy of chronic hepatitis C in a hemodialysis patient in Serbia. The patient infected with genotype 1a has been successfully treated with Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir and Ribavirin. There are only a few real world reports regarding this therapeutic option in hemodialysis patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research